- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 132.26M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $10.14M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $832.04M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $831.58M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.5M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $2.5M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $192.17M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $182.03M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.16B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.16B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $354.28M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $323.09M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.24B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.23B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $29.33M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $41.77M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $152.82M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 132.44M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.45M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $29.66M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $62.44M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $40.73M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.23 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.24 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $14.65M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $9.2M |
| Net Income | Q1 2025 · Mar 31, 2024 | $30.49M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $34.67M |
| Revenue | Q1 2025 · Mar 31, 2024 | $104.32M |